Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?

Ita Fitzgerald; Laura J. Sahm; Ciara Ní Dhubhlaing; Sarah O’Dwyer; Jean O’Connell; Jennifer Torrens; Erin K. Crowley

doi:10.3389/fpsyt.2024.1491417

Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?

Ita Fitzgerald
, Laura J. Sahm
, Ciara Ní Dhubhlaing
, Sarah O’Dwyer
, Jean O’Connell
, Jennifer Torrens
, Erin K. Crowley

School of Pharmacy

Mental Health Ireland
College of Mental Health Pharmacy
University College Dublin

Research output: Contribution to journal › Comment/Debate

Original language	English
Article number	1491417
Journal	Frontiers in Psychiatry
Volume	15
DOIs	https://doi.org/10.3389/fpsyt.2024.1491417
Publication status	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

antipsychotics
metformin
obesity
psychosis
schizophrenia
weight gain

Access to Document

10.3389/fpsyt.2024.1491417

Cite this

@article{7ec6cf89a1ff45a097c4d3be7983bb4a,

title = "Metformin in the management of antipsychotic-induced weight gain – why the {\textquoteleft}weight{\textquoteright}?",

keywords = "antipsychotics, metformin, obesity, psychosis, schizophrenia, weight gain",

author = "Ita Fitzgerald and Sahm, \{Laura J.\} and \{N{\'i} Dhubhlaing\}, Ciara and Sarah O{\textquoteright}Dwyer and Jean O{\textquoteright}Connell and Jennifer Torrens and Crowley, \{Erin K.\}",

year = "2024",

doi = "10.3389/fpsyt.2024.1491417",

language = "English",

volume = "15",

journal = "Frontiers in Psychiatry",